antimelanoma antibodies (MabCure)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantimelanoma antibodies (MabCure)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMabCure Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMabCure Inc
Active IndicationsN/A
Inactive IndicationsMelanoma

Other Information

ATC CodeN/A
Related LinksN/A